TUI 3D in Diagnosis of Placenta Accreta: Comparison With Gray-scale and Color Doppler Techniques
NCT ID: NCT02712099
Last Updated: 2017-05-15
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2015-08-31
2016-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Magnetic Resonance Imaging (MRI ) Versus Ultrasound in Placenta Accreta Diagnosis
NCT03813212
3D Placental Volume in Placenta Accreta
NCT06755047
Doppler Imaging and Morbidly Adherent Placenta
NCT03267446
Role of Ultrasound in Diagnosis of Placenta Previa and MAP
NCT03416296
Ultrasound Model to Help Differentiate Between Placenta Accreta Spectrum and Uterine Dehiscence in 3rd Trimester Pregnancies
NCT07236060
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* All patients will undergo the following :
1. History taking
2. Clinical examination.
3. For each patient, the whole placenta will be scanned in a systematic fashion using both 2D grayscale and 2D power Doppler ultrasound then displayed by 3D TUI to determine whether those patients suspected of having advanced invasive placentation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Placenta previa with its lower edge covering the scar of previous cesarean section
3. From 28 wks to Full term.
Exclusion Criteria
2. Medical disorder as diabetes mellitus, hypertension.
3. Obese patients. BMI \> 30
4. Intrauterine growth retardation.
20 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rehab Mohamed Abdelrahman
Lecturer of Obstetrics and Gynaecology Faculty of Medicine, Ain Shams University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TUI 3D
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.